Based on our findings, we postulate that this is due to an enhanced immune infiltration and/or activation, and not to a PD-L1 upregulation that has been attributed to CXCR3 chemokines in the cancer microenvironment before [33, 35]. Here, CXCR3 is linked to cancer.